TAKARA HOLDINGS INC.

TAKARA HOLDINGS INC.

16.10
EUR
0.00
(0.00%)
1.61BMarket Cap
Nov 05Next Earn
TAKARA HOLDINGS INC.
FRA:TAX
(Frankfurt Stock Exchange)

Recent

price

16.10

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
912.14
960.81
986.71
1,036.12
1,090.76
1,119.97
1,163.84
1,336.49
1,389.79
1,412.58
1,408.38
1,522.06
1,773.69
1,722.24
1,857.56
2,040.16
- -
Revenue per Share
18.21
19.32
23.01
50.82
28.36
35.06
42.14
54.97
52.15
45.11
53.48
105.05
107.26
82.09
82.98
60.51
- -
Basic EPS, GAAP
30.15
43.58
39.11
35.76
47.43
51.55
63.74
81.07
67.67
59
137.07
82.83
230.03
148.07
82.74
89.6
- -
Free Cash Flow per Basic Share
8.6
8.55
9.09
9.03
11
10.01
11.99
13.03
15.98
18.03
19.98
20.98
36.95
38.08
28.98
31.32
- -
Dividend per Share
453.57
461.4
493.13
603.42
655.59
647.96
671.1
726.9
742.35
747.38
793.53
912.57
1,031.59
1,171.09
1,255.93
1,344.6
1,344.6
Book Value per Share
424.58
435.92
466.38
545.47
594.18
593.24
620.13
615.35
642.6
652.8
713.16
834.88
951.01
1,077.18
1,042.55
1,031.6
1,031.6
Tangible Book Value per Share
208
207
204
202
201
201
201
201
200
199
198
198
198
197
195
193
194
Basic Weighted Avg Shares
189,769
198,690
200,989
209,568
219,490
225,364
234,193
268,142
277,443
281,191
278,443
300,918
350,665
339,372
362,693
394,316
- -
Sales/Revenue/Turnover
4.39
4.66
4.54
4.53
5.06
5.18
5.79
5.82
6.42
5.63
7.76
14.41
10.82
6.55
5.68
4.33
- -
Operating Margin (%)
4,551
4,431
4,251
4,287
4,662
5,179
5,757
7,273
7,355
8,473
8,933
9,300
10,116
11,178
12,074
15,354
- -
Depreciation Expense
3,788
3,995
4,687
10,280
5,706
7,055
8,480
11,029
10,411
8,980
10,574
20,769
21,206
16,176
16,202
11,696
- -
Net Income, GAAP
46.14
48.58
43.3
40.96
44.43
38.08
36.38
33.72
30.07
31.66
30.73
28.3
27.72
32.29
32.9
53.59
- -
Effective Tax Rate (%)
2
2.01
2.33
4.91
2.6
3.13
3.62
4.11
3.75
3.19
3.8
6.9
6.05
4.77
4.47
2.97
- -
Profit Margin (%)
78,254
74,831
83,891
101,888
105,776
111,425
108,406
118,355
117,189
113,354
126,839
153,172
174,059
164,556
172,014
167,277
167,277
Working Capital
25,561
20,496
25,417
25,310
30,334
30,255
20,996
35,620
30,772
28,986
38,587
38,253
39,638
52,464
79,276
85,303
85,303
LT Debt
106,894
107,659
114,316
146,420
158,403
156,147
165,918
176,217
179,793
181,327
191,534
224,554
255,316
280,462
300,902
310,935
310,935
Total Equity
3.02
3.19
3.31
3.17
3.08
3.53
4.13
4.64
5.39
4.68
6.29
11.55
9.14
4.57
3.71
1.96
- -
Return on Invested Capital (%)
2.77
2.78
3.07
6
2.82
3.39
4.04
4.68
4
3.42
3.13
4.83
4.83
4.6
4.2
3.9
- -
Return on Capital (%)
3.97
4.23
4.81
9.28
4.5
5.38
6.39
7.87
7.1
6.07
6.94
12.31
11.03
7.48
6.84
4.64
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Jun'26
Sep'26
Mar'26
ST Debt
- -
6,347
11,414
LT Borrowings
- -
55,524
50,431
LT Finance Leases
- -
- -
34,872
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
193
193
193
Market Capitalization
229,157
331,328
295,411

Working Capital

JPY

•

in mil. unless spec.
Jun'26
Sep'26
Mar'26
Total Current Assets
- -
224,183
249,314
Cash, Cash Equivalents & STI
- -
60,558
73,191
Accounts Receivable, Net
- -
71,939
66,621
Inventories
- -
82,942
91,529
Total Current Liabilities
- -
67,616
82,037
Payables & Accruals
- -
- -
- -
ST Debt
- -
6,347
11,414
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.24%
10.28%
3.33%
Free Cash Flow
21.61%
12.97%
7.2%
Net Income, GAAP
9.58%
9.43%
-27.81%
Sales/Revenue/Turnover
5.92%
7.39%
8.72%
Total Cash Common Dividend
13.9%
13.24%
6.98%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
81,510
81,662
90,446
85,754
339,372
2025
- -
- -
- -
- -
362,693
2026
- -
- -
- -
- -
394,316

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
25.11
15.57
29.81
11.45
82.09
2025
- -
- -
- -
- -
82.98
2026
- -
- -
- -
- -
60.51

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
38.08
2025
- -
- -
- -
- -
28.98
2026
- -
- -
- -
- -
31.32
Business
Takara Holdings Inc. is a holding company primarily engaged in the manufacture and sale of alcoholic beverages, seasonings, biomedical products, and related services through its subsidiaries. Takara Shuzo produces and sells Japanese alcoholic beverages (washu) including shochu, sake, and light-alcohol refreshers; imported Chinese alcoholic beverages and whisky; seasonings such as Hon-mirin; and raw alcohol. Takara Shuzo International Group exports Japanese liquors, manufactures and sells alcoholic beverages overseas, and wholesales Japanese foodstuffs including seafood, rice, and seasonings. Takara Bio Group supplies genetic research reagents and instruments under brands such as TaKaRa, Clontech, and Cellartis; genetic testing kits; genome analysis services; iPS cell research products; CDMO services for regenerative medicine including viral vectors, gene therapy, and cell processing; and contract research for biologics development. The company operates across domestic and international markets, with subsidiaries in Japan, the United States (Berkeley, CA; Frankfort, KY; El Monte, CA), United Kingdom, France, Spain, Portugal, Germany, Australia, China, Canada, India, and South Korea, focusing on alcoholic beverages, Japanese food wholesale, life sciences, printing, real estate leasing, logistics, and marketing services. Founded in 1925 and headquartered in Kyoto, Japan, Takara Holdings traces its origins to a sake brewery established in 1842 and employs approximately 5,729 people on a consolidated basis. In recent developments, Takara Shuzo International completed the acquisition of 90% membership interest in Germany's Kagerer & Co. GmbH, a Japanese food wholesaler specializing in seafood and Asian foods, in December 2024 to expand its European wholesale network under the TaKaRa Group Medium-Term Management Plan for 2025. Takara Bio USA Holdings acquired Curio Bioscience in January 2025, enhancing its spatial genomics and single-cell NGS capabilities with the Trekker platform.